[go: up one dir, main page]

PL2191828T3 - Przeciwgrzybicza kompozycja farmaceutyczna - Google Patents

Przeciwgrzybicza kompozycja farmaceutyczna

Info

Publication number
PL2191828T3
PL2191828T3 PL08829675T PL08829675T PL2191828T3 PL 2191828 T3 PL2191828 T3 PL 2191828T3 PL 08829675 T PL08829675 T PL 08829675T PL 08829675 T PL08829675 T PL 08829675T PL 2191828 T3 PL2191828 T3 PL 2191828T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
antifungal pharmaceutical
antifungal
composition
pharmaceutical
Prior art date
Application number
PL08829675T
Other languages
English (en)
Inventor
Takaaki Masuda
Naoto Nishida
Naoko Kobayashi
Hideaki Sasagawa
Original Assignee
Pola Pharma Inc.
Nihon Nohyaku Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Pharma Inc., Nihon Nohyaku Co., Ltd. filed Critical Pola Pharma Inc.
Publication of PL2191828T3 publication Critical patent/PL2191828T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL08829675T 2007-09-05 2008-09-05 Przeciwgrzybicza kompozycja farmaceutyczna PL2191828T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007229617 2007-09-05

Publications (1)

Publication Number Publication Date
PL2191828T3 true PL2191828T3 (pl) 2017-02-28

Family

ID=40428956

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08829675T PL2191828T3 (pl) 2007-09-05 2008-09-05 Przeciwgrzybicza kompozycja farmaceutyczna

Country Status (9)

Country Link
US (2) US9480678B2 (pl)
EP (1) EP2191828B1 (pl)
JP (1) JP5453093B2 (pl)
KR (1) KR20100068271A (pl)
CN (1) CN101808639B (pl)
ES (1) ES2591030T3 (pl)
HU (1) HUE030028T2 (pl)
PL (1) PL2191828T3 (pl)
WO (1) WO2009031644A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007102242A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
WO2007102241A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
WO2007102243A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
CN101808638B (zh) 2007-09-05 2012-07-25 宝丽制药股份有限公司 抗真菌组合物
CN101808639B (zh) 2007-09-05 2012-12-05 宝丽制药股份有限公司 抗真菌医药组合物
KR20100075475A (ko) * 2007-09-05 2010-07-02 가부시키가이샤 폴라 파마 의약 조성물
EP2745692A1 (en) * 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc anti-fungal formulation containing luliconazole
EP2416757A2 (en) 2009-04-09 2012-02-15 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101409792B1 (ko) 2009-04-09 2014-06-19 니혼노야쿠가부시키가이샤 항진균성 약제학적 조성물
JP5635075B2 (ja) 2009-08-25 2014-12-03 株式会社ポーラファルマ 抗真菌医薬組成物
KR101806304B1 (ko) 2010-06-11 2017-12-07 가부시키가이샤 폴라 파마 항진균성 약학적 조성물
CN104619320A (zh) 2012-09-14 2015-05-13 宝丽制药股份有限公司 含有卢立康唑的药物组合物
CN104619703A (zh) 2012-09-14 2015-05-13 宝丽制药股份有限公司 具有结晶习性的晶体以及通过对所述晶体进行加工获得的药物组合物
CN104619704B (zh) 2012-09-14 2017-12-05 宝丽制药股份有限公司 表面自由能用于分化评价晶体的用途，基于表面自由能作为指标评价的晶体，以及通过包含所述晶体制备的药物组合物
JP5589130B1 (ja) 2012-09-14 2014-09-10 株式会社ポーラファルマ 結晶及び該結晶を含有してなる医薬製剤
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
US11554108B2 (en) 2016-08-29 2023-01-17 Xeropedix, Inc. Methods and compositions for treating cutaneous fungal infections
US10251822B2 (en) 2016-08-29 2019-04-09 Xeropedix, Inc. Methods and compositions for treating cutaneous fungal infections
US10898470B1 (en) * 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
JP7361004B2 (ja) * 2020-09-08 2023-10-13 信越化学工業株式会社 アルコール組成物の製造方法

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267169A (en) 1978-07-22 1981-05-12 Toko Yakuhin Kogyo Kabushiki Kaisha Novel preparation of clotrimazole
JPS5815909A (ja) 1981-07-22 1983-01-29 Toko Yakuhin Kogyo Kk 抗真菌外用剤
US4636520A (en) 1984-07-16 1987-01-13 Fujisawa Pharmaceutical Co., Ltd. Antifungal composition employing pyrrolnitrin in combination with an imidazole compound
JPH0236572B2 (ja) 1984-11-13 1990-08-17 Hokuriku Pharmaceutical Suteroidoo177monoesuteruganjukuriimuzai
JPS6293227A (ja) 1985-10-19 1987-04-28 Nippon Nohyaku Co Ltd 抗真菌剤
US4764381A (en) 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
JPH0774144B2 (ja) 1986-03-12 1995-08-09 久光製薬株式会社 尿素を含有する皮膚用組成物
US5686489A (en) 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
JPH0818983B2 (ja) * 1987-12-08 1996-02-28 塩野義製薬株式会社 水虫治療剤
JPH01246219A (ja) 1988-03-25 1989-10-02 Nippon Nohyaku Co Ltd 抗真菌外用クリーム組成物
JPH01242525A (ja) 1988-03-25 1989-09-27 Nippon Nohyaku Co Ltd 抗真菌外用剤
JP3030780B2 (ja) 1988-12-29 2000-04-10 日本農薬株式会社 光学活性なケテンジチオアセタール誘導体及びその製造方法
JPH02264723A (ja) 1989-04-06 1990-10-29 Taisho Pharmaceut Co Ltd 抗真菌剤
JP2963537B2 (ja) 1989-05-26 1999-10-18 アボツト・ラボラトリーズ クラリトロマイシンの注射用組成物
IL97012A0 (en) 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
EP0542931B1 (en) * 1990-08-09 1999-12-08 Genentech, Inc. Serine protease variants having peptide ligase activity
US5340836A (en) 1991-02-19 1994-08-23 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
JP2555555B2 (ja) 1991-07-03 1996-11-20 武田薬品工業株式会社 抗真菌性外用製剤
JPH0570351A (ja) 1991-09-17 1993-03-23 Lion Corp 医療用製剤
JPH0665076A (ja) 1992-08-19 1994-03-08 Pola Chem Ind Inc 抗真菌外用剤
JPH06199701A (ja) 1992-12-29 1994-07-19 Lion Corp 外用消炎鎮痛剤
JPH06211651A (ja) 1993-01-12 1994-08-02 Hisamitsu Pharmaceut Co Inc 爪白癬治療用組成物
JPH0774144A (ja) 1993-06-29 1995-03-17 Sony Corp プラズマ装置のクリーニング方法
UA41937C2 (uk) 1993-07-01 2001-10-15 Яманаухі Еуропе Б.В. Стабільна місцеводіюча ретиноідна композиція
DE4337945A1 (de) 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
JP2860748B2 (ja) 1993-12-24 1999-02-24 エスエス製薬株式会社 安定な酪酸ヒドロコルチゾン含有クリーム剤
JP3803393B2 (ja) 1994-01-12 2006-08-02 久光製薬株式会社 爪白癬治療用組成物
JP3629283B2 (ja) 1994-02-15 2005-03-16 ポーラ化成工業株式会社 皮膚外用剤
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
JP3522832B2 (ja) 1994-06-21 2004-04-26 ポーラ化成工業株式会社 経皮吸収促進剤及び皮膚外用剤
GB9420355D0 (en) 1994-10-10 1994-11-23 Univ Nottingham Preparation of protein microspheres, films and coatings
WO1996011710A1 (en) 1994-10-13 1996-04-25 Hisamitsu Pharmaceutical Co., Inc. External preparation for nail ringworm
SE9502244D0 (sv) 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
JP3278738B2 (ja) 1995-07-08 2002-04-30 日本農薬株式会社 抗真菌剤
AT407832B (de) 1995-07-08 2001-06-25 Nihon Nohyaku Co Ltd Fungizides mittel, eine verbindung hierfür, verfahren zu ihrer herstellung und verfahren zu ihrer verwendung
CA2230448A1 (en) 1995-08-28 1997-03-06 Showa Yakuhin Kako Co., Ltd. Composition for local anesthesia
US5993787A (en) 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
JP4253047B2 (ja) 1996-09-27 2009-04-08 杏林製薬株式会社 被膜形成性抗真菌剤組成物
JP4227677B2 (ja) 1996-12-10 2009-02-18 杏林製薬株式会社 被膜形成性抗真菌剤組成物
JPH10226686A (ja) 1996-12-10 1998-08-25 Nippon Nohyaku Co Ltd 光学活性体である（ｒ）−（ｅ）−（４−置換フェニル−１，３−ジチオラン−２−イリデン）−１−イミダゾールアセトニトリル誘導体及び抗真菌剤及びそれらの製造方法
KR20010005792A (ko) * 1997-03-31 2001-01-15 다케다 야쿠힌 고교 가부시키가이샤 아졸 화합물, 이의 제조 방법 및 용도
WO2000001384A1 (fr) 1998-07-01 2000-01-13 Lead Chemical Co., Ltd. Preparation a base de ketotifene destinee a etre absorbee par voie percutanee
US5962536A (en) 1998-07-31 1999-10-05 Komer; Gene Injectable propofol formulations
AU5404399A (en) 1998-09-10 2000-04-03 Ipr-Institute For Pharmaceutical Research Ag Topical application products
JP2000169372A (ja) 1998-09-29 2000-06-20 Takeda Chem Ind Ltd 抗真菌薬組成物
US20040208906A1 (en) 1999-07-12 2004-10-21 Daiichi Suntory Pharma Co., Ltd. Pharmaceutical composition for topical administration
JP2001064206A (ja) 1999-08-30 2001-03-13 Isp Japan Kk 経皮吸収促進組成物
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US6428654B1 (en) 2000-04-05 2002-08-06 Hercules Incorporated Fungicidal method
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
JP2002193755A (ja) * 2000-12-28 2002-07-10 Sansho Seiyaku Co Ltd フケ・カユミ防止頭髪用および洗髪用化粧料
JP2002284702A (ja) 2001-01-19 2002-10-03 Teika Seiyaku Kk 外用抗真菌製剤
KR100423666B1 (ko) 2001-02-07 2004-03-18 보령제약 주식회사 항진균 외용 제제
US6585963B1 (en) 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US20030017207A1 (en) 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
JP2002363070A (ja) 2001-06-06 2002-12-18 Yuutoku Yakuhin Kogyo Kk 経皮吸収貼付剤
DE60217880T2 (de) 2001-09-04 2007-11-15 Trommsdorff Gmbh & Co. Kg Arzneimittel Pflaster mit sertaconazol zur behandlung von nagelfunktionsstörungen und erkrankungen
JP2003252798A (ja) 2002-02-28 2003-09-10 Shiseido Co Ltd 抗菌ゲル製剤
US8039452B2 (en) 2002-06-18 2011-10-18 Pola Pharma Inc. Antifungal medicinal compositions
US6846837B2 (en) 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails
JP4387639B2 (ja) 2002-07-16 2009-12-16 久光製薬株式会社 経皮吸収製剤
WO2004021968A2 (en) 2002-09-05 2004-03-18 Galderma Research & Development, S.N.C. Solution for ungual application
CA2502986C (en) 2002-10-25 2011-08-23 Foamix Ltd. Cosmetic and pharmaceutical foam
DK1635770T3 (da) 2003-03-21 2009-08-03 Nexmed Holdings Inc Antifungal neglelak og anvendelsesmetode
EA012599B1 (ru) 2003-04-10 2009-10-30 Ньюроджескс, Инк. Способы и композиции для введения агонистов trpv1
WO2005000287A1 (ja) 2003-06-25 2005-01-06 Hisamitsu Pharmaceutical Co., Inc. 水虫治療用外用剤
JP2005104924A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 外用医薬組成物
JP4431369B2 (ja) * 2003-11-21 2010-03-10 久光製薬株式会社 抗真菌エアゾール外用製剤
JP2005203536A (ja) * 2004-01-15 2005-07-28 Matsushita Electric Ind Co Ltd 光送信器
US20080021098A1 (en) * 2004-02-24 2008-01-24 Givaudan Sa Antifungal Compositions
JP4429035B2 (ja) 2004-02-27 2010-03-10 久光製薬株式会社 角質貯留性を高めた外用クリーム製剤
JP3783104B2 (ja) 2004-03-31 2006-06-07 小林製薬株式会社 抗真菌性外用組成物
JP4990617B2 (ja) 2004-06-15 2012-08-01 久光製薬株式会社 消炎鎮痛外用剤
JP4690672B2 (ja) 2004-07-20 2011-06-01 岩城製薬株式会社 乳剤性皮膚外用剤
JP3800232B2 (ja) 2004-09-30 2006-07-26 小林製薬株式会社 抗真菌性外用組成物
JP2006306734A (ja) 2005-04-26 2006-11-09 Tsumura & Co 尿素配合外用剤
JP5290582B2 (ja) 2005-12-28 2013-09-18 帝國製薬株式会社 爪用医薬組成物
WO2007102243A1 (ja) 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
WO2007102242A1 (ja) 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
WO2007102241A1 (ja) 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
CN101808639B (zh) 2007-09-05 2012-12-05 宝丽制药股份有限公司 抗真菌医药组合物
CN101808638B (zh) 2007-09-05 2012-07-25 宝丽制药股份有限公司 抗真菌组合物
KR20100075475A (ko) 2007-09-05 2010-07-02 가부시키가이샤 폴라 파마 의약 조성물
EP2745692A1 (en) 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc anti-fungal formulation containing luliconazole
EP2416757A2 (en) 2009-04-09 2012-02-15 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101409792B1 (ko) 2009-04-09 2014-06-19 니혼노야쿠가부시키가이샤 항진균성 약제학적 조성물

Also Published As

Publication number Publication date
WO2009031644A1 (ja) 2009-03-12
EP2191828A1 (en) 2010-06-02
CN101808639A (zh) 2010-08-18
US20100168200A1 (en) 2010-07-01
US9480678B2 (en) 2016-11-01
EP2191828A4 (en) 2010-09-15
HUE030028T2 (en) 2017-04-28
KR20100068271A (ko) 2010-06-22
JP5453093B2 (ja) 2014-03-26
JPWO2009031644A1 (ja) 2010-12-16
ES2591030T3 (es) 2016-11-24
CN101808639B (zh) 2012-12-05
US20160361299A1 (en) 2016-12-15
EP2191828B1 (en) 2016-08-10

Similar Documents

Publication Publication Date Title
HUS1800007I1 (hu) Gyógyászati készítmény
PL2191828T3 (pl) Przeciwgrzybicza kompozycja farmaceutyczna
EP2133095A4 (en) PHARMACEUTICAL COMPOSITION
EP2133094A4 (en) PHARMACEUTICAL COMPOSITION
IL201891A0 (en) Novel pharmaceutical composition
IL228817A0 (en) Pharmaceutical compounds
IL200125A0 (en) Pharmaceutical composition
EP2224805A4 (en) PHARMACEUTICAL COMPOSITION
EP2206430A4 (en) ANTIMYCOTIC COMPOSITION
EP2224915A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0712389D0 (en) A Pharmaceutical composition
IL208387A0 (en) Pharmaceutical composition
EP2224808A4 (en) PHARMACEUTICAL COMPOSITION
EP2146695A4 (en) PHARMACEUTICAL COMPOSITIONS
ZA201000925B (en) Antifungal composition
EP2124959A4 (en) PHARMACEUTICAL COMPOSITION
ZA201006224B (en) Pharmaceutical composition
GB2464200B (en) Pharmaceutical composition
IL205975A0 (en) Pharmaceutical composition
GB0817969D0 (en) Pharmaceutical composition
IL205931A0 (en) Pharmaceutical composition
EP2204173A4 (en) PHARMACEUTICAL COMPOSITION HAVING ANTIDIABETIC EFFECT
GB0717036D0 (en) Pharmaceutical composition
GB0712558D0 (en) Pharmaceutical composition
AP2007004090A0 (en) Novel pharmaceutical composition